srch

Investor contact Kristin Hodous Senior Manager, Investor Relationsir@blueprintmedicines.com 617.714.6674 Media contact Andrew Law Director, ...

Head of Investor Relations Blueprint Medicines. Geoffrey Grande, CFA, is an accomplished communications executive with significant experience leading ...

21.10.2021 · Except as required by law, Blueprint Medicines expressly disclaims any obligation to update the information contained in such press releases after the date of their issuance. Investor contact Kristin Hodous Senior Manager, Investor Relations investors@blueprintmedicines.com 617.714.6674 Media contact Andrew Law Associate Director, Product Communications …

Blueprint Medicines Appoints Daniella Beckman to its Board of Directors Dec 07, 2021 Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) More News Events and presentations Nov 29, 2021 Blueprint Medicines Conference Call Oct 28, 2021 Q3 2021 Blueprint Medicines Corp Conference Call More events and presentations

30.09.2021 · About Blueprint Medicines. Blueprint Medicines is a global precision therapy company that invents life-changing therapies for people with cancer and hematologic disorders. ... Investor Relations investors@blueprintmedicines.com 617.714.6674 Media contact Andrew Law Associate Director, ...

Sr. Manager, Investor Relations at Blueprint Medicines. Blueprint MedicinesConverse College. Cambridge, Massachusetts, United States500+ connections.

Geoffrey works at Blueprint Medicines as Head Of Investor Relations. Geoffrey is based out of Greater Boston and works in the Biotechnology ...

Investor contact Kristin Hodous Senior Manager, Investor Relations investors@blueprintmedicines.com 617.714.6674 Media contact Andrew Law Associate Director ...

Kristin Hodous is Senior Mgr:Investor Relations at Blueprint Medicines. See Kristin Hodous's compensation, career history, education, & memberships.

The Investor Relations website contains information about Blueprint Medicines Corp.'s business for stockholders, potential investors, and financial analysts.

11 timer siden · Shares of Blueprint Medicines Corporation BPMC have rallied 24.8% in the past six months against the industry’s decrease of 18.7%.. Image Source: Zacks Investment Research. The company has made ...

Blueprint Medicines Corp Banner Image ... Blueprint Medicines Corporation, a biopharmaceutical company, ... MOST RECENT 2020 Annual Report and Form 10K.

9, 2021) / PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) ... oversees finance, investor relations, and business development.

The Investor Relations website contains information about Blueprint Medicines Corp.'s business for stockholders, potential investors, and financial analysts.

29.11.2021 · The Investor Relations website contains information about Blueprint Medicines Corp.'s business for stockholders, potential investors, and financial analysts.